Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.47 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11688737 | 0.89 | FDPS (0.50) | FDPSSMPD1GGPS1 | |
| Butane SCHEMBL27837597 | 0.87 | MEN1 (0.39) | FDPSSMPD1CYP2D6TSHRCYP2C19 | |
| SCHEMBL4095717 | 0.85 | FDPS (0.53) | FDPSSMPD1GGPS1 | |
| SCHEMBL870763 | 0.83 | TSHR (0.39) | FDPSSMPD1CYP2D6TSHRCYP2C19 | |
| SCHEMBL6505412 | 0.83 | FDPS (0.46) | FDPSSMPD1GGPS1 | |
| SCHEMBL5691553 | 0.83 | ALDH1A1 (0.42) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL11343284 | 0.82 | TSHR (0.35) | FDPSCYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL22514 | 0.82 | ALDH1A1 (0.35) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL25187865 | 0.80 | ALDH1A1 (0.34) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL10336350 | 0.80 | ALDH1A1 (0.34) | CYP2D6TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0659702-B1 | Method of cementing a subterranean zone | HALLIBURTON ENERGY SERV INC (US) | 1998-07-15 | — | — | EP | claimed |
| EP-0659702-A1 | Method of cementing a subterranean zone | HALLIBURTON COMPANY (US) | 1995-06-28 | — | — | EP | claimed |
| US-5398759-A | Acids, phosphonates, phosphinates | HALLIBURTON COMPANY (US) | 1995-03-21 | — | — | US | claimed |
| US-20100129338-A1 | SNAIL BAIT | BAYER CROPSCIENCE AG (DE) | 2010-05-27 | — | — | US | disclosed |
| EP-0659702-A1 | Method of cementing a subterranean zone | HALLIBURTON COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
| US-5398759-A | Acids, phosphonates, phosphinates | HALLIBURTON COMPANY (US) | 1995-03-21 | — | — | US | disclosed |
| US-4252857-A | Flameproofing substrate | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | disclosed |
| US-4133872-A | Compositions for preparation of aqueous solutions of salts of lower valence 99 technetium | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1979-01-09 | — | — | US | disclosed |
| US-4086334-A | A CALCITONIN AND AN ADJUVANT CONTAINING CARBOXY AND/OR PHOSPHONO GROUPS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DT) | 1978-04-25 | — | — | US | disclosed |
| US-3962433-A | Method of treatment of calcium disorders using phosphonoalkane-polycarboxylic acids | HENKEL & CIE G.M.B.H. (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129338-A1 | SNAIL BAIT | ALG3, STOM, ITCH | FDPS 792/4885SMPD1 2303/4885CYP2D6 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.